Press Release

Article

Patient Navigation in Oncology at Heart of Priority Health White House Visit

On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.

First Lady Dr Jill Biden | Image Credit: The White House

First Lady Dr Jill Biden | Image Credit: The White House

Praveen Thadani | Image Credit: Priority Health

Praveen Thadani | Image Credit: Priority Health

Grand Rapids, Michigan — President and CEO of Priority Health Praveen Thadani traveled to the White House in late March to participate in a Cancer Moonshot discussion on how to improve and optimize patient navigation services in the oncology space, alongside First Lady Dr Jill Biden.

The first lady and Thadani, who recently lost his father to cancer, both emphasized the vital role a patient navigator fills for patients on this difficult, often uncertain, journey, noting that navigators help guide patients and their families and caregivers through the complex maze of the cancer care system.

“I saw firsthand through my father’s experience how complicated the journey can be,” said Thadani. “When you suffer from cancer, you go through a range of emotions, including fear, loss, anxiety and feeling overwhelmed. Navigators are a positive first step to offer much-needed support for cancer patients, caregivers and families during such a complex journey.”

The second largest health plan in Michigan, Priority Health servies more than 1.3 million members, offering both Medicare and Medicaid plan options.

Learn more here.

Related Videos
Neil Goldfarb, GPBCH
Dr Bonnie Qin
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
dr carol regueiro
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
dr carol regueiro
dr carol regueiro
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Mabel Mardones, MD.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo